{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:31:05Z","timestamp":1773160265922,"version":"3.50.1"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T00:00:00Z","timestamp":1184284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T00:00:00Z","timestamp":1184284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1038\/sj.cdd.4402196","type":"journal-article","created":{"date-parts":[[2007,7,13]],"date-time":"2007-07-13T09:18:19Z","timestamp":1184318299000},"page":"1561-1575","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression?"],"prefix":"10.1038","volume":"14","author":[{"given":"A","family":"Olsson","sequence":"first","affiliation":[]},{"given":"C","family":"Manzl","sequence":"additional","affiliation":[]},{"given":"A","family":"Strasser","sequence":"additional","affiliation":[]},{"given":"A","family":"Villunger","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,7,13]]},"reference":[{"key":"BF4402196_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP . p53 in health and disease. Nat Rev Mol Cell Biol 2007; 8: 275\u2013283.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BF4402196_CR2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1023\/A:1025365432325","volume":"23","author":"JE Chipuk","year":"2003","unstructured":"Chipuk JE, Green DR . p53's believe it or not: lessons on transcription-independent death. J Clin Immunol 2003; 23: 355\u2013361.","journal-title":"J Clin Immunol"},{"key":"BF4402196_CR3","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS El-Deiry","year":"1993","unstructured":"El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817\u2013825.","journal-title":"Cell"},{"key":"BF4402196_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S1097-2765(00)80002-7","volume":"1","author":"H Hermeking","year":"1997","unstructured":"Hermeking H, Lengauer C, Polyak K, He TC, Zhang L, Thiagalingam S et al. 14-3-3 sigma is a p53-regulated inhibitor of G2\/M progression. Mol Cell 1997; 1: 3\u201311.","journal-title":"Mol Cell"},{"key":"BF4402196_CR5","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/0092-8674(92)90593-2","volume":"71","author":"MB Kastan","year":"1992","unstructured":"Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV et al. A mammalian cell cycle checkpoint pathway utilizing p53 and lang2057GADD45 is defective in ataxia-telangiectasia. Cell 1992; 71: 587\u2013597.","journal-title":"Cell"},{"key":"BF4402196_CR6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ . The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805\u2013816.","journal-title":"Cell"},{"key":"BF4402196_CR7","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/377552a0","volume":"377","author":"J Brugarolas","year":"1995","unstructured":"Brugarolas J, Chandrasekaran C, Gordon JI, Beach D, Jacks T, Hannon GJ . Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 1995; 377: 552\u2013557.","journal-title":"Nature"},{"key":"BF4402196_CR8","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1073\/pnas.96.7.3706","volume":"96","author":"XW Wang","year":"1999","unstructured":"Wang XW, Zhan Q, Coursen JD, Khan MA, Kontny HU, Yu L et al. GADD45 induction of a G2\/M cell cycle checkpoint. Proc Natl Acad Sci USA 1999; 96: 3706\u20133711.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR9","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/44188","volume":"401","author":"TA Chan","year":"1999","unstructured":"Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B . 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 1999; 401: 616\u2013620.","journal-title":"Nature"},{"key":"BF4402196_CR10","doi-asserted-by":"publisher","first-page":"8696","DOI":"10.1038\/sj.onc.1206034","volume":"21","author":"S Jin","year":"2002","unstructured":"Jin S, Tong T, Fan W, Fan F, Antinore MJ, Zhu X et al. GADD45-induced cell cycle G2-M arrest associates with altered subcellular distribution of cyclin B1 and is independent of p38 kinase activity. Oncogene 2002; 21: 8696\u20138704.","journal-title":"Oncogene"},{"key":"BF4402196_CR11","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1038\/sj.onc.1202667","volume":"18","author":"Q Zhan","year":"1999","unstructured":"Zhan Q, Antinore MJ, Wang XW, Carrier F, Smith ML, Harris CC et al. Association with Cdc2 and inhibition of Cdc2\/Cyclin B1 kinase activity by the p53-regulated protein Gadd45. Oncogene 1999; 18: 2892\u20132900.","journal-title":"Oncogene"},{"key":"BF4402196_CR12","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.282.5393.1497","volume":"282","author":"F Bunz","year":"1998","unstructured":"Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497\u20131501.","journal-title":"Science"},{"key":"BF4402196_CR13","doi-asserted-by":"publisher","first-page":"42971","DOI":"10.1074\/jbc.M106460200","volume":"276","author":"T Ando","year":"2001","unstructured":"Ando T, Kawabe T, Ohara H, Ducommun B, Itoh M, Okamoto T . Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2\/M arrest after DNA damage. J Biol Chem 2001; 276: 42971\u201342977.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR14","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","volume":"116","author":"NN Danial","year":"2004","unstructured":"Danial NN, Korsmeyer SJ . Cell death: critical control points. Cell 2004; 116: 205\u2013219.","journal-title":"Cell"},{"key":"BF4402196_CR15","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2005.03.183","volume":"331","author":"E Michalak","year":"2005","unstructured":"Michalak E, Villunger A, Erlacher M, Strasser A . Death squads enlisted by the tumour suppressor p53. Biochem Biophys Res Commun 2005; 331: 786\u2013798.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF4402196_CR16","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1128\/MCB.25.5.2000-2013.2005","volume":"25","author":"N Finnberg","year":"2005","unstructured":"Finnberg N, Gruber JJ, Fei P, Rudolph D, Bric A, Kim SH et al. DR5 knockout mice are compromised in radiation-induced apoptosis. Mol Cell Biol 2005; 25: 2000\u20132013.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR17","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S1074-7613(00)80609-3","volume":"9","author":"EE Varfolomeev","year":"1998","unstructured":"Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL et al. Targeted disruption of the mouse Caspase 8 gene ablates cell death induction by the TNF receptors, Fas\/Apo1, and DR3 and is lethal prenatally. Immunity 1998; 9: 267\u2013276.","journal-title":"Immunity"},{"key":"BF4402196_CR18","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/35078527","volume":"3","author":"MC Moroni","year":"2001","unstructured":"Moroni MC, Hickman ES, Denchi EL, Caprara G, Colli E, Cecconi F et al. Apaf-1 fe1031 is a transcriptional target for E2F and p53. Nat Cell Biol 2001; 3: 552\u2013558.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1083\/jcb.200105137","volume":"155","author":"A Fortin","year":"2001","unstructured":"Fortin A, Cregan SP, MacLaurin JG, Kushwaha N, Hickman ES, Thompson CS et al. APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death. J Cell Biol 2001; 155: 207\u2013216.","journal-title":"J Cell Biol"},{"key":"BF4402196_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0092-8674(00)81732-8","volume":"94","author":"F Cecconi","year":"1998","unstructured":"Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P . Apaf-1 (CED-4 homologue) regulates programmed cell death in mammalian development. Cell 1998; 94: 727\u2013737.","journal-title":"Cell"},{"key":"BF4402196_CR21","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0092-8674(00)81733-X","volume":"94","author":"H Yoshida","year":"1998","unstructured":"Yoshida H, Kong Y-Y, Yoshida R, Elia AJ, Hakem A, Hakem R et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 1998; 94: 739\u2013750.","journal-title":"Cell"},{"key":"BF4402196_CR22","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nature01101","volume":"419","author":"VS Marsden","year":"2002","unstructured":"Marsden VS, O\u2019Connor L, O\u2019Reilly LA, Silke J, Metcalf D, Ekert PG et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c\/Apaf-1\/caspase-9 apoptosome. Nature 2002; 419: 634\u2013637.","journal-title":"Nature"},{"key":"BF4402196_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ceb.2005.10.001","volume":"17","author":"SN Willis","year":"2005","unstructured":"Willis SN, Adams JM . Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 2005; 17: 617\u2013625.","journal-title":"Curr Opin Cell Biol"},{"key":"BF4402196_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0092-8674(95)90513-8","volume":"80","author":"T Miyashita","year":"1995","unstructured":"Miyashita T, Reed JC . Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995; 80: 293\u2013299.","journal-title":"Cell"},{"key":"BF4402196_CR25","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/sj.cdd.4400562","volume":"6","author":"T Schmidt","year":"1999","unstructured":"Schmidt T, Korner K, Karsunky H, Korsmeyer S, Muller R, Moroy T . The activity of the murine bax promoter is regulated by Sp1\/3 and E-box binding proteins but not by p53. Cell Death Differ 1999; 6: 873\u2013882.","journal-title":"Cell Death Differ"},{"key":"BF4402196_CR26","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1097-2765(00)00136-2","volume":"6","author":"T Lindsten","year":"2000","unstructured":"Lindsten T, Ross AJ, King A, Zong W, Rathmell JC, Shiels HA et al. The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol Cell 2000; 6: 1389\u20131399.","journal-title":"Mol Cell"},{"key":"BF4402196_CR27","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1101\/gad.897601","volume":"15","author":"WX Zong","year":"2001","unstructured":"Zong WX, Lindsten T, Ross AJ, MacGregor GR, Thompson CB . BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 2001; 15: 1481\u20131486.","journal-title":"Genes Dev"},{"key":"BF4402196_CR28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1126\/science.270.5233.96","volume":"270","author":"CM Knudson","year":"1995","unstructured":"Knudson CM, Tung KSK, Tourtellotte WG, Brown GAJ, Korsmeyer SJ . Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 1995; 270: 96\u201399.","journal-title":"Science"},{"key":"BF4402196_CR29","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1073\/pnas.94.6.2345","volume":"94","author":"ME McCurrach","year":"1997","unstructured":"McCurrach ME, Connor TMF, Knudson CM, Korsmeyer SJ, Lowe SW . Bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis. Proc Nat Acad Sci USA 1997; 94: 2345\u20132349.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF4402196_CR30","first-page":"4328","volume":"60","author":"S Kondo","year":"2000","unstructured":"Kondo S, Shinomura Y, Miyazaki Y, Kiyohara T, Tsutsui S, Kitamura S et al. Mutations of the bak gene in human gastri c and colorectal cancers. Cancer Res 2000; 60: 4328\u20134330.","journal-title":"Cancer Res"},{"key":"BF4402196_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/ncb866","volume":"4","author":"JK Sax","year":"2002","unstructured":"Sax JK, Fei P, Murphy ME, Bernhard E, Korsmeyer SJ, El-Deiry WS . BID regulation by p53 contributes to chemosensitivity. Nat Cell Biol 2002; 4: 842\u2013849.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR32","doi-asserted-by":"publisher","first-page":"13430","DOI":"10.1074\/jbc.M108029200","volume":"277","author":"Y Guo","year":"2002","unstructured":"Guo Y, Srinivasula SM, Druilhe A, Fernandes-Alnemri T, Alnemri ES . Caspase-2 induces apoptosis by releasing proapoptotic proteins from mitochondria. J Biol Chem 2002; 277: 13430\u201313437.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR33","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1074\/jbc.274.2.1156","volume":"274","author":"A Gross","year":"1999","unstructured":"Gross A, Yin X-M, Wang K, Wei MC, Jockel J, Milliman C et al. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1\/Fas death. J Biol Chem 1999; 274: 1156\u20131163.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR34","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/sj.cdd.4401033","volume":"9","author":"LA O\u2019Reilly","year":"2002","unstructured":"O\u2019Reilly LA, Ekert P, Harvey N, Marsden V, Cullen L, Vaux DL et al. Caspase-2 is not required for thymocyte or neuronal apoptosis even though cleavage of caspase-2 is dependent on both Apaf-1 and caspase-9. Cell Death Differ 2002; 9: 832\u2013841.","journal-title":"Cell Death Differ"},{"key":"BF4402196_CR35","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1083\/jcb.200312030","volume":"165","author":"VS Marsden","year":"2004","unstructured":"Marsden VS, Ekert PG, Van Delft M, Vaux DL, Adams JM, Strasser A . Bcl-2-regulated apoptosis and cytochrome c release can occur independently of both caspase-2 and caspase-9. J Cell Biol 2004; 165: 775\u2013780.","journal-title":"J Cell Biol"},{"key":"BF4402196_CR36","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cell.2005.06.014","volume":"122","author":"I Kamer","year":"2005","unstructured":"Kamer I, Sarig R, Zaltsman Y, Niv H, Oberkovitz G, Regev L et al. Proapoptotic BID is an ATM effector in the DNA-damage response. Cell 2005; 122: 593\u2013603.","journal-title":"Cell"},{"key":"BF4402196_CR37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cell.2005.06.022","volume":"122","author":"SS Zinkel","year":"2005","unstructured":"Zinkel SS, Hurov KE, Ong C, Abtahi FM, Gross A, Korsmeyer SJ . A role for proapoptotic BID in the DNA-damage response. Cell 2005; 122: 579\u2013591.","journal-title":"Cell"},{"key":"BF4402196_CR38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cell.2007.03.017","volume":"129","author":"T Kaufmann","year":"2007","unstructured":"Kaufmann T, Tai L, Ekert PG, Huang DC, Norris F, Lindemann RK et al. The BH3-only protein bid is dispensable for DNA damage- and rep licative stress-induced apoptosis or cell-cycle arrest. Cell 2007; 129: 423\u2013433.","journal-title":"Cell"},{"key":"BF4402196_CR39","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","volume":"7","author":"K Nakano","year":"2001","unstructured":"Nakano K, Vousden KH . PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7: 683\u2013694.","journal-title":"Mol Cell"},{"key":"BF4402196_CR40","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1073\/pnas.201208798","volume":"98","author":"J Han","year":"2001","unstructured":"Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, Lutz RJ et al. Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Nat Acad Sci USA 2001; 98: 11318\u201311323.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF4402196_CR41","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1097-2765(01)00213-1","volume":"7","author":"J Yu","year":"2001","unstructured":"Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B . PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7: 673\u2013682.","journal-title":"Mol Cell"},{"key":"BF4402196_CR42","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","volume":"288","author":"E Oda","year":"2000","unstructured":"Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T et al. Noxa, a BH3-only member of the bcl-2 fami ly and candidate mediator of p53-induced apoptosis. Science 2000; 288: 1053\u20131058.","journal-title":"Science"},{"key":"BF4402196_CR43","doi-asserted-by":"publisher","first-page":"4632","DOI":"10.1128\/jvi.64.10.4632-4639.1990","volume":"64","author":"M Hijikata","year":"1990","unstructured":"Hijikata M, Kato N, Sato T, Kagami Y, Shimotohno K . Molecular cloning and characterization of a cDNA for a novel phorbol-12-myristate-13-acetate-responsive gene that is highly expressed in an adult T-cell leukemia cell line. J Virol 1990; 64: 4632\u20134639.","journal-title":"J Virol"},{"key":"BF4402196_CR44","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1126\/science.1090072","volume":"302","author":"A Villunger","year":"2003","unstructured":"Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ et al. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 2003; 302: 1036\u20131038.","journal-title":"Science"},{"key":"BF4402196_CR45","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1101\/gad.1103603","volume":"17","author":"T Shibue","year":"2003","unstructured":"Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A et al. Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 2003; 17: 2233\u20132238.","journal-title":"Genes Dev"},{"key":"BF4402196_CR46","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1535-6108(03)00244-7","volume":"4","author":"JR Jeffers","year":"2003","unstructured":"Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, Brennan J et al. Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003; 4: 321\u2013328.","journal-title":"Cancer Cell"},{"key":"BF4402196_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1083\/jcb.200608070","volume":"176","author":"E Naik","year":"2007","unstructured":"Naik E, Michalak EM, Villunger A, Adams JM, Strasser A . Ultraviolet radiation triggers apoptosis of fibroblasts and skin keratinocytes mainly via the BH3-only protein Noxa. J Cell Biol 2007; 176: 415\u2013424.","journal-title":"J Cell Biol"},{"key":"BF4402196_CR48","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1182\/blood-2005-04-1595","volume":"131","author":"M Erlacher","year":"2005","unstructured":"Erlacher M, Michalak EM, Kelly PN, Labi V, Niederegger H, Coultas L et al. BH3-only proteins Puma and Bim are rate-limiting for {gamma} -radiation and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 2005; 131: 4131\u20134138.","journal-title":"Blood"},{"key":"BF4402196_CR49","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20061552","volume":"203","author":"M Erlacher","year":"2006","unstructured":"Erlacher M, Labi V, Manzl C, Bock G, Tzankov A, Hacker G et al. Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J Exp Med 2006; 203: 2939\u20132951.","journal-title":"J Exp Med"},{"key":"BF4402196_CR50","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S1535-6108(03)00272-1","volume":"4","author":"JE Chipuk","year":"2003","unstructured":"Chipuk JE, Maurer U, Green DR, Schuler M . Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell 2003; 4: 371\u2013381.","journal-title":"Cancer Cell"},{"key":"BF4402196_CR51","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1092734","volume":"303","author":"JE Chipuk","year":"2004","unstructured":"Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M et al. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 2004; 303: 1010\u20131014.","journal-title":"Science"},{"key":"BF4402196_CR52","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S1097-2765(03)00050-9","volume":"11","author":"M Mihara","year":"2003","unstructured":"Mihara M, Erster S, Zaika A, Petrenko O, Chittenden T, Pancoska P et al. p53 has a direct apoptogenic role at the mitochondria. Mol Cell 2003; 11: 577\u2013590.","journal-title":"Mol Cell"},{"key":"BF4402196_CR53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/ncb1123","volume":"6","author":"JI Leu","year":"2004","unstructured":"Leu JI, Dumont P, Hafey M, Murphy ME, George DL . Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol 2004; 6: 443\u2013450.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR54","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/ncb1499","volume":"8","author":"H Kim","year":"2006","unstructured":"Kim H, Rafiuddin-Shah M, Tu HC, Jeffers JR, Zambetti GP, Hsieh JJ et al. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat Cell Biol 2006; 8: 1348\u20131358.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR55","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1073\/pnas.0700020104","volume":"104","author":"P Wang","year":"2007","unstructured":"Wang P, Yu J, Zhang L . The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci USA 2007; 104: 4054\u20134059.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR56","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nrc1455","volume":"4","author":"AM Bode","year":"2004","unstructured":"Bode AM, Dong Z . Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 2004; 4: 793\u2013805.","journal-title":"Nat Rev Cancer"},{"key":"BF4402196_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cell.2005.07.034","volume":"123","author":"M Takagi","year":"2005","unstructured":"Takagi M, Absalon MJ, McLure KG, Kastan MB . Regulation of p53 translation and induction after DNA damage by ribosomal protein L26 and nucleolin. Cell 2005; 123: 49\u201363.","journal-title":"Cell"},{"key":"BF4402196_CR58","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nature03147","volume":"432","author":"RT Phan","year":"2004","unstructured":"Phan RT, Dalla-Favera R . The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004; 432: 635\u2013639.","journal-title":"Nature"},{"key":"BF4402196_CR59","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.tibs.2003.10.004","volume":"28","author":"G Melino","year":"2003","unstructured":"Melino G, Lu X, Gasco M, Crook T, Knight RA . Functional regulation of p73 and p63: development and cancer. Trends Biochem Sci 2003; 28: 663\u2013670.","journal-title":"Trends Biochem Sci"},{"key":"BF4402196_CR60","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1101\/gad.1339905","volume":"19","author":"JC Bourdon","year":"2005","unstructured":"Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP et al. p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005; 19: 2122\u20132137.","journal-title":"Genes Dev"},{"key":"BF4402196_CR61","first-page":"127","volume":"5","author":"D Wolf","year":"1985","unstructured":"Wolf D, Harris N, Goldfinger N, Rotter V . Isolation of a full-length mouse cDNA clone coding for an immunologically distinct p53 molecule. Mol Cell Biol 1985; 5: 127\u2013132.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR62","first-page":"813","volume":"12","author":"JM Flaman","year":"1996","unstructured":"Flaman JM, Waridel F, Estreicher A, Vannier A, Limacher JM, Gilbert D et al. The human tumour suppressor gene p53 is alternatively spliced in normal cells. Oncogene 1996; 12: 813\u2013818.","journal-title":"Oncogene"},{"key":"BF4402196_CR63","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.biocel.2004.11.014","volume":"37","author":"H Scrable","year":"2005","unstructured":"Scrable H, Sasaki T, Maier B . DeltaNp53 or p44: prim ing the p53 pump. Int J Biochem Cell Biol 2005; 37: 913\u2013919.","journal-title":"Int J Biochem Cell Biol"},{"key":"BF4402196_CR64","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2005.04.032","volume":"122","author":"G Rohaly","year":"2005","unstructured":"Rohaly G, Chemnitz J, Dehde S, Nunez AM, Heukeshoven J, Deppert W et al. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 2005; 122: 21\u201332.","journal-title":"Cell"},{"key":"BF4402196_CR65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/415045a","volume":"415","author":"SD Tyner","year":"2002","unstructured":"Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002; 415: 45\u201353.","journal-title":"Nature"},{"key":"BF4402196_CR66","doi-asserted-by":"publisher","first-page":"6225","DOI":"10.1093\/emboj\/cdf595","volume":"21","author":"I Garcia-Cao","year":"2002","unstructured":"Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, Criado LM, Klatt P, Flores JM et al. Super p53\u2032 mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J 2002; 21: 6225\u20136235.","journal-title":"EMBO J"},{"key":"BF4402196_CR67","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1002\/j.1460-2075.1995.tb00123.x","volume":"14","author":"J Mosner","year":"1995","unstructured":"Mosner J, Mummenbrauer T, Bauer C, Sczakiel G, Grosse F, Deppert W . Negative feedback regulation of wild-type p53 biosynthesis. EMBO J 1995; 14: 4442\u20134449.","journal-title":"EMBO J"},{"key":"BF4402196_CR68","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1101\/gad.1162404","volume":"18","author":"B Maier","year":"2004","unstructured":"Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 2004; 18: 306\u2013319.","journal-title":"Genes Dev"},{"key":"BF4402196_CR69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.mrfmmm.2004.08.022","volume":"576","author":"LD Attardi","year":"2005","unstructured":"Attardi LD, Donehower LA . Probing p53 biological functions through the use of genetically engineered mouse models. Mutat Res 2005; 576: 4\u201321.","journal-title":"Mutat Res"},{"key":"BF4402196_CR70","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/nrc2012","volume":"6","author":"F Toledo","year":"2006","unstructured":"Toledo F, Wahl GM . Regulating the p53 pathway: in vitro hypotheses, in vivo veritas. Nat Rev Cancer 2006; 6: 909\u2013923.","journal-title":"Nat Rev Cancer"},{"key":"BF4402196_CR71","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1128\/MCB.24.3.976-984.2004","volume":"24","author":"HK Sluss","year":"2004","unstructured":"Sluss HK, Armata H, Gallant J, Jones SN . Phosphorylation of serine 18 regulates distinct p53 functions in mice. Mol Cell Biol 2004; 24: 976\u2013984.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR72","doi-asserted-by":"publisher","first-page":"41028","DOI":"10.1074\/jbc.M306938200","volume":"278","author":"C Sluss Chao","year":"2003","unstructured":"Sluss Chao C, Hergenhahn M, Kaeser MD, Wu Z, Saito S, Iggo R et al. Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J Biol Chem 2003; 278: 41028\u201341033.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR73","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1128\/MCB.22.8.2441-2449.2002","volume":"22","author":"Z Wu","year":"2002","unstructured":"Wu Z, Earle J, Saito S, Anderson CW, Appella E, Xu Y . Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol 2002; 22: 2441\u20132449.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR74","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1038\/sj.emboj.7600363","volume":"23","author":"D MacPherson","year":"2004","unstructured":"MacPherson D, Kim J, Kim T, Rhee BK, Van Oostrom CT, DiTullio RA et al. Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J 2004; 23: 3689\u20133699.","journal-title":"EMBO J"},{"key":"BF4402196_CR75","first-page":"2615","volume":"25","author":"C Chao","year":"2006","unstructured":"Chao C, Herr D, Chun J, Xu Y . Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression. EMBO J 2006; 25: 2615\u20132622.","journal-title":"EMBO J"},{"key":"BF4402196_CR76","doi-asserted-by":"publisher","first-page":"2812","DOI":"10.4161\/cc.5.23.3526","volume":"5","author":"L Feng","year":"2006","unstructured":"Feng L, Hollstein M, Xu Y . Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence. Cell Cycle 2006; 5: 2812\u20132819.","journal-title":"Cell Cycle"},{"key":"BF4402196_CR77","doi-asserted-by":"publisher","first-page":"8884","DOI":"10.1128\/MCB.24.20.8884-8894.2004","volume":"24","author":"W Bruins","year":"2004","unstructured":"Bruins W, Zwart E, Attardi LD, Iwakuma T, Hoogervorst EM, Beems RB et al. Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 2004; 24: 8884\u20138894.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR78","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1128\/MCB.25.13.5389-5395.2005","volume":"25","author":"L Feng","year":"2005","unstructured":"Feng L, Lin T, Uranishi H, Gu W, Xu Y . Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol 2005; 25: 5389\u20135395.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR79","doi-asserted-by":"publisher","first-page":"10188","DOI":"10.1073\/pnas.0503068102","volume":"102","author":"KA Krummel","year":"2005","unstructured":"Krummel KA, Lee CJ, Toledo F, Wahl GM . The C-terminal lysines fine-tune P53 stress responses in a mouse model but are not required for stability control or transactivation. Proc Natl Acad Sci USA 2005; 102: 10188\u201310193.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR80","doi-asserted-by":"publisher","first-page":"6859","DOI":"10.1128\/MCB.00062-06","volume":"26","author":"C Chao","year":"2006","unstructured":"Chao C, Wu Z, Mazur SJ, Borges H, Rossi M, Lin T et al. Acetylation of mouse p53 at lysine 317 negatively regulates p53 apoptotic activities after DNA damage. Mol Cell Biol 2006; 26: 6859\u20136869.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR81","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/79152","volume":"26","author":"GS Jimenez","year":"2000","unstructured":"Jimenez GS, Nister M, Stommel JM, Beeche M, Barcarse EA, Zhang XQ et al. A transactivation-deficient mouse model provides insights into Trp53 regulation and function. Nat Genet 2000; 26: 37\u201343.","journal-title":"Nat Genet"},{"key":"BF4402196_CR82","doi-asserted-by":"publisher","first-page":"4967","DOI":"10.1093\/emboj\/19.18.4967","volume":"19","author":"C Chao","year":"2000","unstructured":"Chao C, Saito S, Kang J, Anderson CW, Appella E, Xu Y . p53 transcriptional activity is essential for p53-dependent apoptosis following DNA damage. EMBO J 2000; 19: 4967\u20134975.","journal-title":"EMBO J"},{"key":"BF4402196_CR83","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/ng1498","volume":"37","author":"TM Johnson","year":"2005","unstructured":"Johnson TM, Hammond EM, Giaccia A, Attardi LD . The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality. Nat Genet 2005; 37: 145\u2013152.","journal-title":"Nat Genet"},{"key":"BF4402196_CR84","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.ccr.2006.03.014","volume":"9","author":"F Toledo","year":"2006","unstructured":"Toledo F, Krummel KA, Lee CJ, Liu CW, Rodewald LW, Tang M et al. A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network. Cancer Cell 2006; 9: 273\u2013285.","journal-title":"Cancer Cell"},{"key":"BF4402196_CR85","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1128\/MCB.00999-06","volume":"27","author":"F Toledo","year":"2007","unstructured":"Toledo F, Lee CJ, Krummel KA, Rodewald LW, Liu CW, Wahl GM . Mouse mutants reveal that putative protein interaction sites in the p53 proline-rich domain are dispensable for tumor suppression. Mol Cell Biol 2007; 27: 1425\u20131432.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR86","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","volume":"75","author":"M Scheffner","year":"1993","unstructured":"Scheffner M, Huibregtse JM, Vierstra RD, Howley PM . The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993; 75: 495\u2013505.","journal-title":"Cell"},{"key":"BF4402196_CR87","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/nature02514","volume":"429","author":"D Dornan","year":"2004","unstructured":"Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429: 86\u201392.","journal-title":"Nature"},{"key":"BF4402196_CR88","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0092-8674(03)00193-4","volume":"112","author":"RP Leng","year":"2003","unstructured":"Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003; 112: 779\u2013791.","journal-title":"Cell"},{"key":"BF4402196_CR89","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.cell.2005.03.037","volume":"121","author":"D Chen","year":"2005","unstructured":"Chen D, Kon N, Li M, Zhang W, Qin J, Gu W . ARF-BP1\/Mule is a critical mediator of the ARF tumor suppressor. Cell 2005; 121: 1071\u20131083.","journal-title":"Cell"},{"key":"BF4402196_CR90","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.molcel.2006.01.020","volume":"21","author":"CL Brooks","year":"2006","unstructured":"Brooks CL, Gu W . p53 ubiquitination: Mdm2 and beyond. Mol Cell 2006; 21: 307\u2013315.","journal-title":"Mol Cell"},{"key":"BF4402196_CR91","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ncb1562","volume":"9","author":"S Carter","year":"2007","unstructured":"Carter S, Bischof O, Dejean A, Vousden KH . C-terminal modifications regulate MDM2 dissociation and nuclear export of p53. Nat Cell Biol 2007; 9: 428\u2013435.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR92","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1126\/science.1091362","volume":"302","author":"M Li","year":"2003","unstructured":"Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W . Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003; 302: 1972\u20131975.","journal-title":"Science"},{"key":"BF4402196_CR93","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/378206a0","volume":"378","author":"SN Jones","year":"1995","unstructured":"Jones SN, Roe AE, Donehower LA, Bradley A . Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995; 378: 206\u2013208.","journal-title":"Nature"},{"key":"BF4402196_CR94","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/378203a0","volume":"378","author":"R Montes de Oca Luna","year":"1995","unstructured":"Montes de Oca Luna R, Wagner DS, Lozano G . Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378: 203\u2013206.","journal-title":"Nature"},{"key":"BF4402196_CR95","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cell.2004.06.016","volume":"118","author":"DP Xirodimas","year":"2004","unstructured":"Xirodimas DP, Saville MK, Bourdon JC, Hay RT, Lane DP . Mdm2-mediated NEDD8 conjugation of p53 inhibits its transcriptional activity. Cell 2004; 118: 83\u201397.","journal-title":"Cell"},{"key":"BF4402196_CR96","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1074\/jbc.M609001200","volume":"282","author":"WM Abida","year":"2007","unstructured":"Abida WM, Nikolaev A, Zhao W, Zhang W, Gu W . FBXO11 promotes the Neddylation of p53 and inhibits its transcriptional activity. J Biol Chem 2007; 282: 1797\u20131804.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR97","doi-asserted-by":"publisher","first-page":"6462","DOI":"10.1093\/emboj\/18.22.6462","volume":"18","author":"M Gostissa","year":"1999","unstructured":"Gostissa M, Hengstermann A, Fogal V, Sandy P, Schwarz SE, Scheffner M et al. Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J 1999; 18: 6462\u20136471.","journal-title":"EMBO J"},{"key":"BF4402196_CR98","doi-asserted-by":"publisher","first-page":"6455","DOI":"10.1093\/emboj\/18.22.6455","volume":"18","author":"MS Rodriguez","year":"1999","unstructured":"Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT . SUMO-1 modification activates the transcriptional response of p53. EMBO J 1999; 18: 6455\u20136461.","journal-title":"EMBO J"},{"key":"BF4402196_CR99","doi-asserted-by":"publisher","first-page":"5348","DOI":"10.1038\/sj.onc.1206851","volume":"22","author":"L Chen","year":"2003","unstructured":"Chen L, Chen J . MDM2-ARF complex regulates p53 sumoylation. Oncogene 2003; 22: 5348\u20135357.","journal-title":"Oncogene"},{"key":"BF4402196_CR100","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1073\/pnas.052559499","volume":"99","author":"D Schmidt","year":"2002","unstructured":"Schmidt D, Muller S . Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc Natl Acad Sci USA 2002; 99: 2872\u20132877.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR101","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1038\/sj.onc.1204362","volume":"20","author":"SS Kwek","year":"2001","unstructured":"Kwek SS, Derry J, Tyner AL, Shen Z, Gudkov AV . Functional analysis and intracellular localization of p53 modified by SUMO-1. Oncogene 2001; 20: 2587\u20132599.","journal-title":"Oncogene"},{"key":"BF4402196_CR102","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nature01116","volume":"419","author":"H Zheng","year":"2002","unstructured":"Zheng H, You H, Zhou XZ, Murray SA, Uchida T, Wulf G et al. The prolyl is omerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002; 419: 849\u2013853.","journal-title":"Nature"},{"key":"BF4402196_CR103","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01120","volume":"419","author":"P Zacchi","year":"2002","unstructured":"Zacchi P, Gostissa M, Uchida T, Salvagno C, Avolio F, Volinia S et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002; 419: 853\u2013857.","journal-title":"Nature"},{"key":"BF4402196_CR104","doi-asserted-by":"publisher","first-page":"8846","DOI":"10.1128\/MCB.23.23.8846-8861.2003","volume":"23","author":"D Dornan","year":"2003","unstructured":"Dornan D, Shimizu H, Burch L, Smith AJ, Hupp TR . The proline repeat domain of p53 binds directly to the transcriptional coactivator p300 and allosterically controls DNA-dependent acetylation of p53. Mol Cell Biol 2003; 23: 8846\u20138861.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR105","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1101\/gad.12.18.2831","volume":"12","author":"K Sakaguchi","year":"1998","unstructured":"Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 1998; 12: 2831\u20132841.","journal-title":"Genes Dev"},{"key":"BF4402196_CR106","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/42981","volume":"387","author":"NL Lill","year":"1997","unstructured":"Lill NL, Grossman SR, Ginsberg D, DeCaprio J, Livingston DM . Binding and modulation of p53 by p300\/CBP coactivators. Nature 1997; 387: 823\u2013827.","journal-title":"Nature"},{"key":"BF4402196_CR107","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1038\/sj.onc.1203500","volume":"19","author":"J Roth","year":"2000","unstructured":"Roth J, Koch P, Contente A, Dobbelstein M . Tu mor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain. Oncogene 2000; 19: 1834\u20131842.","journal-title":"Oncogene"},{"key":"BF4402196_CR108","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/sj.onc.1205015","volume":"21","author":"N Baptiste","year":"2002","unstructured":"Baptiste N, Friedlander P, Chen X, Prives C . The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells. Oncogene 2002; 21: 9\u201321.","journal-title":"Oncogene"},{"key":"BF4402196_CR109","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S0960-9822(95)00183-7","volume":"5","author":"JF Armstrong","year":"1995","unstructured":"Armstrong JF, Kaufman MH, Harrison DJ, Clarke AR . High-frequency developmental abnormalities in p53-deficient mice. Curr Biol 1995; 5: 931\u2013936.","journal-title":"Curr Biol"},{"key":"BF4402196_CR110","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/ng0695-175","volume":"10","author":"VP Sah","year":"1995","unstructured":"Sah VP, Attardi LD, Mulligan GJ, Williams BO, Bronson RT, Jacks T . A subset of p53-deficient embryos exhibit exencephaly. Nat Genet 1995; 10: 175\u2013180.","journal-title":"Nat Genet"},{"key":"BF4402196_CR111","doi-asserted-by":"publisher","first-page":"11936","DOI":"10.1073\/pnas.220252297","volume":"97","author":"C Chao","year":"2000","unstructured":"Chao C, Saito S, Anderson CW, Appella E, Xu Y . Phosphorylation of murine p53 at ser-18 regulates the p53 responses to DNA damage. Proc Natl Acad Sci USA 2000; 97: 11936\u201311941.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR112","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/38291","volume":"389","author":"K Somasundaram","year":"1997","unstructured":"Somasundaram K, Zhang H, Zeng YX, Houvras Y, Peng Y, Zhang H et al. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1\/CiP1. Nature 1997; 389: 187\u2013190.","journal-title":"Nature"},{"key":"BF4402196_CR113","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1006\/excr.1999.4403","volume":"248","author":"T Haapajarvi","year":"1999","unstructured":"Haapajarvi T, Kivinen L, Heiskanen A, des Bordes C, Datto MB, Wang XF et al. UV radiation is a transcriptional inducer of p21(Cip1\/Waf1) cyclin-kinase inhibitor in a p53-independent manner. Exp Cell Res 1999; 248: 272\u2013279.","journal-title":"Exp Cell Res"},{"key":"BF4402196_CR114","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1128\/MCB.21.4.1297-1310.2001","volume":"21","author":"C Koumenis","year":"2001","unstructured":"Koumenis C, Alarcon R, Hammond E, Sutphin P, Hoffman W, Murphy M et al. Regulation of p53 by hypoxia: dissociation of transcriptional repression and apoptosis from p53-dependent transactivation. Mol Cell Biol 2001; 21: 1297\u20131310.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR115","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/542","volume":"19","author":"MJ Waterman","year":"1998","unstructured":"Waterman MJ, Stavridi ES, Waterman JL, Halazonetis TD . ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet 1998; 19: 175\u2013178.","journal-title":"Nat Genet"},{"key":"BF4402196_CR116","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1046\/j.1432-1327.2001.02225.x","volume":"26","author":"E Appella","year":"2001","unstructured":"Appella E, Anderson CW . Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 2001; 26: 2764\u20132772.","journal-title":"Eur J Biochem"},{"key":"BF4402196_CR117","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","volume":"281","author":"S Banin","year":"1998","unstructured":"Banin S, Moyal L, Shieh S-Y, Taya Y, Anderson CW, Chessa L et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281: 1674\u20131677.","journal-title":"Science"},{"key":"BF4402196_CR118","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","volume":"91","author":"S-Y Shieh","year":"1997","unstructured":"Shieh S-Y, Ikeda M, Taya Y, Prives C . DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 1997; 91: 325\u2013334.","journal-title":"Cell"},{"key":"BF4402196_CR119","first-page":"1519","volume":"8","author":"M Fiscella","year":"1993","unstructured":"Fiscella M, Ullrich SJ, Zambrano N, Shields MT, Lin D, Lees-Miller SP et al. Mutation of the serine 15 phosphorylation site of human p53 reduces the ability of p53 to inhibit cell cycle progression. Oncogene 1993; 8: 1519\u20131528.","journal-title":"Oncogene"},{"key":"BF4402196_CR120","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/3882","volume":"20","author":"KK Khanna","year":"1998","unstructured":"Khanna KK, Keating KE, Kozlov S, Scott S, Gatei M, Hobson K et al. ATM associates with and phosphorylates p53: mapping the region of interaction. Nat Genet 1998; 20: 398\u2013400.","journal-title":"Nat Genet"},{"key":"BF4402196_CR121","doi-asserted-by":"publisher","first-page":"7002","DOI":"10.1093\/emboj\/18.24.7002","volume":"18","author":"N Dumaz","year":"1999","unstructured":"Dumaz N, Meek DW . Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 1999; 18: 7002\u20137010.","journal-title":"EMBO J"},{"key":"BF4402196_CR122","doi-asserted-by":"publisher","first-page":"37536","DOI":"10.1074\/jbc.M305135200","volume":"278","author":"S Saito","year":"2003","unstructured":"Saito S, Yamaguchi H, Higashimoto Y, Chao C, Xu Y, Fornace Jr AJ et al. Phosphorylation site interdependence of human p53 post-translational modifications in response to stress. J Biol Chem 2003; 278: 37536\u201337544.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR123","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/S0014-5793(99)01647-6","volume":"463","author":"N Dumaz","year":"1999","unstructured":"Dumaz N, Milne DM, Meek DW . Protein kinase CK1 is a p53-threonine 18 kinase which requires prior phosphorylation of serine 15. FEBS Lett 1999; 463: 312\u2013316.","journal-title":"FEBS Lett"},{"key":"BF4402196_CR124","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1038\/sj.onc.1202656","volume":"18","author":"T Unger","year":"1999","unstructured":"Unger T, Sionov RV, Moallem E, Yee CL, Howley PM, Oren M et al. Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 1999; 18: 3205\u20133212.","journal-title":"Oncogene"},{"key":"BF4402196_CR125","doi-asserted-by":"publisher","first-page":"13777","DOI":"10.1073\/pnas.96.24.13777","volume":"96","author":"NH Chehab","year":"1999","unstructured":"Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD . Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci USA 1999; 96: 13777\u201313782.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR126","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/ncb714","volume":"4","author":"G D\u2019Orazi","year":"2002","unstructured":"D\u2019Orazi G, Cecchinelli B, Bruno T, Manni I, Higashimoto Y, Saito S et al. Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis. Nat Cell Biol 2002; 4: 11\u201319.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR127","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.molcel.2007.02.007","volume":"25","author":"N Taira","year":"2007","unstructured":"Taira N, Nihira K, Yamaguchi T, Miki Y, Yoshida K . DYRK2 is targeted to the nucleus and controls p53 via Ser46 phosphorylation in the apoptotic response to DNA damage. Mol Cell 2007; 25: 725\u2013738.","journal-title":"Mol Cell"},{"key":"BF4402196_CR128","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0092-8674(00)00073-8","volume":"102","author":"K Oda","year":"2000","unstructured":"Oda K, Arakawa H, Tanaka T, Matsuda K, Tanikawa C, Mori T et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102: 849\u2013862.","journal-title":"Cell"},{"key":"BF4402196_CR129","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1074\/jbc.M003485200","volume":"276","author":"JP Blaydes","year":"2001","unstructured":"Blaydes JP, Luciani MG, Pospisilova S, Ball HM, Vojtesek B, Hupp TR . Stoichiometric phosphorylation of human p53 at Ser315 stimulates p53-dependent transcription. J Biol Chem 2001; 276: 4699\u20134708.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR130","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1038\/sj.emboj.7600735","volume":"24","author":"V Fogal","year":"2005","unstructured":"Fogal V, Hsieh JK, Royer C, Zhong S, Lu X . Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315. EMBO J 2005; 24: 2768\u20132782.","journal-title":"EMBO J"},{"key":"BF4402196_CR131","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/ng1279","volume":"36","author":"H Katayama","year":"2004","unstructured":"Katayama H, Sasai K, Kawai H, Yuan ZM, Bondaruk J, Suzuki F et al. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat Genet 2004; 36: 55\u201362.","journal-title":"Nat Genet"},{"key":"BF4402196_CR132","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1006\/bbrc.1999.1023","volume":"261","author":"D Keller","year":"1999","unstructured":"Keller D, Zeng X, Li X, Kapoor M, Iordanov MS, Taya Y et al. The p38MAPK inhibitor SB203580 alleviates ultraviolet-induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem Biophys Res Commun 1999; 261: 464\u2013471.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF4402196_CR133","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/sj.onc.1203300","volume":"19","author":"M Kapoor","year":"2000","unstructured":"Kapoor M, Hamm R, Yan W, Taya Y, Lozano G . Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation. Oncogene 2000; 19: 358\u2013364.","journal-title":"Oncogene"},{"key":"BF4402196_CR134","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S1097-2765(01)00176-9","volume":"7","author":"DM Keller","year":"2001","unstructured":"Keller DM, Zeng X, Wang Y, Zhang QH, Kapoor M, Shu H et al. A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell 2001; 7: 283\u2013292.","journal-title":"Mol Cell"},{"key":"BF4402196_CR135","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1073\/pnas.95.11.6399","volume":"95","author":"H Lu","year":"1998","unstructured":"Lu H, Taya Y, Ikeda M, Levine AJ . Ultraviolet radiation, but not gamma radiation or etoposide-induced DNA damage, results in the phosphorylation of the murine p53 protein at serine-389. Proc Natl Acad Sci USA 1998; 95: 6399\u20136402.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR136","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.bbrc.2004.08.175","volume":"323","author":"M Yamauchi","year":"2004","unstructured":"Yamauchi M, Suzuki K, Kodama S, Watanabe M . Stabilization of alanine substituted p53 protein at Ser15, Thr18, and Ser20 in response to ionizing radiation. Biochem Biophys Res Commun 2004; 323: 906\u2013911.","journal-title":"Biochem Biophys Res Commun"},{"key":"BF4402196_CR137","first-page":"789","volume":"10","author":"B Fuchs","year":"1995","unstructured":"Fuchs B, O\u2019Connor D, Fallis L, Scheidtmann KH, Lu X . p53 phosphorylation mutants retain transcription activity. Oncogene 1995; 10: 789\u2013793.","journal-title":"Oncogene"},{"key":"BF4402196_CR138","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1038\/sj.onc.1205340","volume":"21","author":"JP Mathai","year":"2002","unstructured":"Mathai JP, Germain M, Marcellus RC, Shore GC . Induction and endoplasmic reticulum location of BIK\/NBK in response to apoptotic signaling by E1A and p53. Oncogene 2002; 21: 2534\u20132544.","journal-title":"Oncogene"},{"key":"BF4402196_CR139","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1126\/science.287.5459.1824","volume":"287","author":"A Hirao","year":"2000","unstructured":"Hirao A, Kong YY, Matsuoka S, Wakeham A, Ruland J, Yoshida H et al. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 2000; 287: 1824\u20131827.","journal-title":"Science"},{"key":"BF4402196_CR140","unstructured":"Michalak E, Coultas L, Villunger A, Adams JM, Strasser A . The apoptosis induced by the tumour suppressor p53 relies largely on Puma but Noxa contributes 2007, submitted."},{"key":"BF4402196_CR141","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1128\/MCB.19.2.1202","volume":"19","author":"L Liu","year":"1999","unstructured":"Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD et al. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 1999; 19: 1202\u20131209.","journal-title":"Mol Cell Biol"},{"key":"BF4402196_CR142","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nature05541","volume":"445","author":"A Ventura","year":"2007","unstructured":"Ventura A, Kirsch DG, McLaughlin ME, Tuveson DA, Grimm J, Lintault L et al. Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661\u2013665.","journal-title":"Nature"},{"key":"BF4402196_CR143","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nature05529","volume":"445","author":"W Xue","year":"2007","unstructured":"Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V et al. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656\u2013660.","journal-title":"Nature"},{"key":"BF4402196_CR144","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.molcel.2007.02.008","volume":"25","author":"C Rinaldo","year":"2007","unstructured":"Rinaldo C, Prodosmo A, Mancini F, Iacovelli S, Sacchi A, Moretti F et al. MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosis. Mol Cell 2007; 25: 739\u2013750.","journal-title":"Mol Cell"},{"key":"BF4402196_CR145","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.onc.1204080","volume":"20","author":"JL Luo","year":"2001","unstructured":"Luo JL, Yang Q, Tong WM, Hergenhahn M, Wang ZQ, Hollstein M . Knock-in mice with a chimeric human\/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: a new biomedical research tool. Oncogene 2001; 20: 320\u2013328.","journal-title":"Oncogene"},{"key":"BF4402196_CR146","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/ncb1211","volume":"7","author":"T Lin","year":"2005","unstructured":"Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E et al. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005; 7: 165\u2013171.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR147","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1073\/pnas.95.6.2834","volume":"95","author":"M Kapoor","year":"1998","unstructured":"Kapoor M, Lozano G . Functional activation of p53 via phosphorylation following DNA damage by UV but not gamma radiation. Proc Natl Acad Sci USA 1998; 95: 2834\u20132837.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF4402196_CR148","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.1158\/0008-5472.CAN-04-4328","volume":"65","author":"EM Hoogervorst","year":"2005","unstructured":"Hoogervorst EM, Bruins W, Zwart E, van Oostrom CT, van den Aardweg GJ, Beems RB et al. Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas. Cancer Res 2005; 65: 3610\u20133616.","journal-title":"Cancer Res"},{"key":"BF4402196_CR149","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","volume":"90","author":"W Gu","year":"1997","unstructured":"Gu W, Roeder RG . Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 1997; 90: 595\u2013606.","journal-title":"Cell"},{"key":"BF4402196_CR150","doi-asserted-by":"publisher","first-page":"25568","DOI":"10.1074\/jbc.M212574200","volume":"278","author":"YH Wang","year":"2003","unstructured":"Wang YH, Tsay YG, Tan BC, Lo WY, Lee SC . Identification and characterization of a novel p300-mediated p53 acetylation site, lysine 305. J Biol Chem 2003; 278: 25568\u201325576.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR151","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.molcel.2006.11.021","volume":"24","author":"Y Tang","year":"2006","unstructured":"Tang Y, Luo J, Zhang W, Gu W . Tip60-dependent acetylation of p53 modulates the decision between cell-cycle arrest and apoptosis. Mol Cell 2006; 24: 827\u2013839.","journal-title":"Mol Cell"},{"key":"BF4402196_CR152","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.molcel.2006.11.026","volume":"24","author":"SM Sykes","year":"2006","unstructured":"Sykes SM, Mellert HS, Holbert MA, Li K, Marmorstein R, Lane WS et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell 2006; 24: 841\u2013851.","journal-title":"Mol Cell"},{"key":"BF4402196_CR153","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/42972","volume":"387","author":"W Gu","year":"1997","unstructured":"Gu W, Shi X-L, Roeder RG . Synergistic activation of transcription by CBP and p53. Nature 1997; 387: 819\u2013823.","journal-title":"Nature"},{"key":"BF4402196_CR154","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S1097-2765(01)00414-2","volume":"8","author":"NA Barlev","year":"2001","unstructured":"Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD et al. Acetylation of p53 activates trans cription through recruitment of coactivators\/histone acetyltransferases. Mol Cell 2001; 8: 1243\u20131254.","journal-title":"Mol Cell"},{"key":"BF4402196_CR155","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S1097-2765(01)00283-0","volume":"8","author":"JM Espinosa","year":"2001","unstructured":"Espinosa JM, Emerson BM . Transcriptional regulation by p53 through intrinsic DNA\/chromatin binding and site-directed cofactor recruitment. Mol Cell 2001; 8: 57\u201369.","journal-title":"Mol Cell"},{"key":"BF4402196_CR156","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0955-0674(03)00003-6","volume":"15","author":"CL Brooks","year":"2003","unstructured":"Brooks CL, Gu W . Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation. Curr Opin Cell Biol 2003; 15: 164\u2013171.","journal-title":"Curr Opin Cell Biol"},{"key":"BF4402196_CR157","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1083\/jcb.200512059","volume":"173","author":"CD Knights","year":"2006","unstructured":"Knights CD, Catania J, Di Giovanni S, Muratoglu S, Perez R, Swartzbeck A et al. Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate. J Cell Biol 2006; 173: 533\u2013544.","journal-title":"J Cell Biol"},{"key":"BF4402196_CR158","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"J Luo","year":"2001","unstructured":"Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A et al. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 2001; 107: 137\u2013148.","journal-title":"Cell"},{"key":"BF4402196_CR159","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/35042612","volume":"408","author":"J Luo","year":"2000","unstructured":"Luo J, Su F, Chen D, Shiloh A, Gu W . Deacetylation of p53 modulates its effect on cell growth and apoptosis. Nature 2000; 408: 377\u2013381.","journal-title":"Nature"},{"key":"BF4402196_CR160","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","volume":"107","author":"H Vaziri","year":"2001","unstructured":"Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK et al. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 2001; 107: 149\u2013159.","journal-title":"Cell"},{"key":"BF4402196_CR161","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1093\/emboj\/20.6.1331","volume":"20","author":"A Ito","year":"2001","unstructured":"Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E et al. p300\/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO J 2001; 20: 1331\u20131340.","journal-title":"EMBO J"},{"key":"BF4402196_CR162","doi-asserted-by":"publisher","first-page":"30838","DOI":"10.1074\/jbc.M204078200","volume":"277","author":"Y Jin","year":"2002","unstructured":"Jin Y, Zeng SX, Dai MS, Yang XJ, Lu H . MDM2 inhibits PCAF (p300\/CREB-binding protein-associated factor)-mediated p53 acetylation. J Biol Chem 2002; 277: 30838\u201330843.","journal-title":"J Biol Chem"},{"key":"BF4402196_CR163","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1093\/emboj\/cdf616","volume":"21","author":"A Ito","year":"2002","unstructured":"Ito A, Kawaguchi Y, Lai CH, Kovacs JJ, Higashimoto Y, Appella E et al. MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J 2002; 21: 6236\u20136245.","journal-title":"EMBO J"},{"key":"BF4402196_CR164","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature03117","volume":"432","author":"S Chuikov","year":"2004","unstructured":"Chuikov S, Kurash JK, Wilson JR, Xiao B, Justin N, Ivanov GS et al. Regulation of p53 activity through lysine methylation. Nature 2004; 432: 353\u2013360.","journal-title":"Nature"},{"key":"BF4402196_CR165","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature05287","volume":"444","author":"J Huang","year":"2006","unstructured":"Huang J, Perez-Burgos L, Placek BJ, Sengupta R, Richter M, Dorsey JA et al. Repression of p53 activity by Smyd2-mediated methylation. Nature 2006; 444: 629\u2013632.","journal-title":"Nature"},{"key":"BF4402196_CR166","doi-asserted-by":"publisher","first-page":"4174","DOI":"10.1073\/pnas.97.8.4174","volume":"97","author":"G Liu","year":"2000","unstructured":"Liu G, McDonnell TJ, Montes de Oca Luna R, Kapoor M, Mims B, El-Naggar AK et al. High metastatic potential in mice inheriting a targeted p53 missense mutation. Proc Nat Acad Sci USA 2000; 97: 4174\u20134179.","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF4402196_CR167","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","volume":"119","author":"GA Lang","year":"2004","unstructured":"Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM et al. Gain of function of a p53 hot spot mutation in a mouse model of Li\u2013Fraumeni syndrome. Cell 2004; 119: 861\u2013872.","journal-title":"Cell"},{"key":"BF4402196_CR168","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/ncb1571","volume":"9","author":"H Song","year":"2007","unstructured":"Song H, Hollstein M, Xu Y . p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat Cell Biol 2007; 9: 573\u2013580.","journal-title":"Nat Cell Biol"},{"key":"BF4402196_CR169","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","volume":"119","author":"KP Olive","year":"2004","unstructured":"Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT et al. Mutant p53 gain of function in two mouse models of Li\u2013Fraumeni syndrome. Cell 2004; 119: 847\u2013860.","journal-title":"Cell"},{"key":"BF4402196_CR170","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1093\/nar\/30.7.1563","volume":"30","author":"JD Wright","year":"2002","unstructured":"Wright JD, Noskov SY, Lim C . Factors governing loss and rescue of DNA binding upon single and double mutations in the p53 core domain. Nucleic Acids Res 2002; 30: 1563\u20131574.","journal-title":"Nucleic Acids Res"}],"container-title":["Cell Death & Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4402196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4402196","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4402196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T04:04:36Z","timestamp":1650341076000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4402196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,13]]},"references-count":170,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["BF4402196"],"URL":"https:\/\/doi.org\/10.1038\/sj.cdd.4402196","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,13]]},"assertion":[{"value":"29 March 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}